Literature DB >> 19375126

Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders.

Gerthe Veen1, Erik J Giltay, Roel H DeRijk, Irene M van Vliet, Johannes van Pelt, Frans G Zitman.   

Abstract

Depressive and anxiety disorders are associated with an increased risk of cardiovascular disease. Chronic stress induces hypothalamus-pituitary-adrenal (HPA)-axis perturbations, which might subsequently induce atherogenic lipoprotein profiles and adiposity. The aim of the present study was to investigate the relationship between basal saliva cortisol levels and serum lipids and adiposity in psychiatric patients. Eight salivary cortisol samples (awakening; 30, 45, and 60 minutes after awakening; 11:00 AM, 3:00 PM, 7:00 PM, and 11:00 PM) on 2 consecutive days in medication-free outpatients with depressive and/or anxiety disorders (n = 72) and in healthy controls (n = 42) were used to derive 2 measures of HPA-axis function: basal cortisol concentrations (ie, area under the curve [AUC(cortisol)]) and circadian cortisol variability (variability(cortisol)). Index z scores were calculated for dyslipidemia (from serum triglycerides, inverse high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol) and adiposity (from body mass index and waist-to-hip ratio). Regression analyses were conducted to determine the contribution of AUC(cortisol) and variability(cortisol) in explaining the variance of, respectively, the lipid and adiposity index. Patients showed a higher mean AUC(cortisol) compared with healthy controls (t = 2.7, P = .01). Both cortisol parameters were independently associated with dyslipidemia in patients after adjustment for age, alcohol use, and smoking habits (beta = .31, P = .02 and beta = -.29, P = .02, respectively), but not in controls. Cortisol measures were not associated with adiposity in either group. We conclude that elevated basal cortisol concentrations and lower circadian cortisol variability were independently associated with a less favorable lipoprotein profile in patients with depressive and/or anxiety disorders. These data lend support to the hypothesis that the relationship between affective disorders and cardiovascular disease is partly mediated by HPA-axis perturbations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375126     DOI: 10.1016/j.metabol.2009.02.009

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

Review 1.  The association between depression and diabetes in the perinatal period.

Authors:  Laura J Rasmussen-Torvik; Bernard L Harlow
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

2.  Effects of chocolate intake on Perceived Stress; a Controlled Clinical Study.

Authors:  Ahmed Al Sunni; Rabia Latif
Journal:  Int J Health Sci (Qassim)       Date:  2014-10

Review 3.  Open questions in current models of antidepressant action.

Authors:  A Tanti; C Belzung
Journal:  Br J Pharmacol       Date:  2010-02-02       Impact factor: 8.739

Review 4.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

5.  Exploring the Ovarian Reserve Within Health Parameters: A Latent Class Analysis.

Authors:  Theresa M Hardy; Mauricio Garnier-Villarreal; Donna O McCarthy; Richard A Anderson; Rebecca M Reynolds
Journal:  West J Nurs Res       Date:  2018-08-09       Impact factor: 1.967

6.  Analgesic effects of ASP3662, a novel 11β-hydroxysteroid dehydrogenase 1 inhibitor, in rat models of neuropathic and dysfunctional pain.

Authors:  Tetsuo Kiso; Toshihiro Sekizawa; Hiroshi Uchino; Mina Tsukamoto; Shuichiro Kakimoto
Journal:  Br J Pharmacol       Date:  2018-08-17       Impact factor: 8.739

7.  Psychobiological Factors Affecting Cortisol Variability in Human-Dog Dyads.

Authors:  Iris Schöberl; Manuela Wedl; Andrea Beetz; Kurt Kotrschal
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

Review 8.  Metabolomic Biomarkers in Anxiety Disorders.

Authors:  Elke Humer; Christoph Pieh; Thomas Probst
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

9.  The relationships of shift work, hair cortisol concentration and dyslipidaemia: a cohort study in China.

Authors:  Lejia Zhu; Yu Zhang; Lin Song; Ziqi Zhou; Jin Wang; Yangmei Wang; Lingli Sang; Jing Xiao; Yulong Lian
Journal:  BMC Public Health       Date:  2022-08-29       Impact factor: 4.135

Review 10.  Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile.

Authors:  Brenda W J H Penninx; Yuri Milaneschi; Femke Lamers; Nicole Vogelzangs
Journal:  BMC Med       Date:  2013-05-15       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.